We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Beckman Coulter's New Solutions Demonstrated at 2013 AACC Annual Meeting

By LabMedica International staff writers
Posted on 01 Aug 2013
Print article
Beckman Coulter (Brea, CA, USA) demonstrated its dedication to advancing and optimizing the lab at the 2013 American Association of Clinical Chemistry (AACC) and Clinical Lab Expo in Houston (TX, USA) from July 30–August 1, 2013.

The Beckman Coulter exhibition booth showcased the company’s latest products in total lab automation, scalable solutions, and small footprint systems, including the new Power Express automation solution which streamlines lab workflow and increases flexibility to ultimately decrease turnaround time. The Power Link, also demonstrated, offers labs the ability to combine an AU680 chemistry analyzer with a DxI immunoassay analyzer to form an entry level automated workcell.

Moreover, the latest addition of the IRIS Diagnostics (Chatsworth, CA, USA) urinalysis portfolio and presentations on the company’s newest troponin I assay, AccuTnI+3 on the Access 2 immunoassay system was demonstrated.

Attendees were given opportunities to view Beckman Coulter's newest cellular analysis systems, high-throughput chemistry analyzers, and clinical information solutions in a unique booth design that exhibits the company’s lab automation for the core, reference, and community hospital lab.

Visitors to Beckman Coulter’s booth have the opportunity to learn from industry experts how the company’s latest diagnostic innovations advance and optimize patient care and hear examples of how Beckman Coulter moves the lab forward by increasing efficiency, productivity, and uptime.

Related Links:
Beckman Coulter
Iris Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.